Skip to main content
. 2012 Oct 31;94(3):753–763. doi: 10.1016/j.rvsc.2012.09.025

Table 6.

Total group and detailed individual clinical score values for each parameter evaluated in Co-Infected cats during rFeIFNω therapy.

Detailed individual clinical scores
Cat 14 Cat 15 Cat 16
Clinical parameter/Day 0 10 30 65 0 10 30 65 0 10 30 65
Oral ulcers 2 2 2 0 0 0 0 0 2 2 1 1
Caudal stomatitis 0 0 0 0 0 0 0 0 2 2 1 1
Ophthalmological abnormalities 0 0 0 0 0 0 0 0 0 0 0 0
Lymphadenopathy 0 0 0 0 0 0 0 0 0 0 0 0
Ocular discharge 0 0 0 0 0 0 0 0 0 0 0 0
Nasal discharge 0 0 0 0 0 0 0 0 0 0 0 0
Mucous membranes 0 0 0 0 0 0 0 0 0 0 0 0
Dry coat/seborrhea 0 0 0 0 0 0 0 0 1 1 1 0
Body condition 0 0 0 0 1 1 1 1 0 0 0 0
Faecal Appearance 0 0 0 0 0 0 0 0 1 1 1 0
Concurrent Diseases 0 0 0 0 0 0 0 0 1 1 1 1



Total (individual) 2 2 2 0 1 1 1 1 7 7 5 3



Total group clinical scores
Day 0 10 30 65
Total (sum) 10 10 8 4